Search the Newsreel

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027

Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …

Form 8K Vivani Medical Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

Vivakor and M2i Global Announce Strategic Collaboration to Advance U.S. Critical Minerals Supply Chain

Vivakor, Inc. and M2i Global, Inc. have entered into an Indication of Interest to explore a potential business combination. The collaboration aims to strengthen the U.S. critical minerals supply chain and advance domestic mineral independence. This strategic move could expand Vivakor's commodities marketing and …

M2i Global and Vivakor sign deal to explore merger to boost US critical minerals supply chain

M2i Global Inc and Vivakor Inc have signed a non-binding agreement to explore a merger. The proposed deal aims to combine M2i's critical minerals platform with Vivakor's commodities marketing and remediation businesses to create a larger US-focused platform. This merger is intended to strengthen …

M2i Global signs deal to explore merger with Vivakor

M2i Global Inc (OTC:MTWO) and Vivakor Inc (NASDAQ:VIVK) have signed a non-binding agreement to explore a merger, aiming to strengthen the US critical minerals supply chain. The potential combination would integrate M2i's critical minerals platform with Vivakor's commodities marketing and remediation businesses. The companies …

Vivakor and M2i Set 30-Day Window to Explore Critical Minerals Deal

Vivakor (Nasdaq: VIVK) and M2i Global (OTCQB: MTWO) have signed an Indication of Interest (IOI) to explore a potential business combination and strategic collaboration focused on advancing the U.S. critical minerals supply chain. The IOI outlines an initial 30-day period for negotiating valuation, transaction …

EXCLUSIVE: Vivakor Targets Critical Minerals Expansion Through Potential M2i Acquisition

Vivakor Inc. (NASDAQ: VIVK) and M2i Global Inc. (OTCQB: MTWO) have signed a non-binding indication of interest to explore a potential business combination. This proposed merger aims to expand Vivakor's operations into critical minerals, support the U.S. critical minerals supply chain, and combine their …

Aviva (LSE:AV.) Tests Whether link between diversified insurance earnings and shareholder distributions Can Endure

HC Wainwright Issues Positive Forecast for Innoviva Earnings

Viva Energy (ASX:VEA) Tests Refining Upswing After Margin Surge

Three Innoviva therapies named finalists for Prix Galien award

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc., announced that three of its infectious disease therapies—XACDURO, ZEVTERA, and NUZOLVENCE—have been named finalists for the 2026 Prix Galien USA Award in the Best Pharmaceutical Product category. This marks the third consecutive year an Innoviva product …

Vivakor reports increased crude oil marketing activity By Investing.com

Vivakor Inc. (NASDAQ:VIVK) has reported increased activity in its physical crude oil marketing platform due to geopolitical uncertainties in the Middle East causing volatility in global crude oil markets. The company's Vivakor Supply & Trading, LLC unit is experiencing higher activity and aims to …

Vivakor Sees Increased Activity as Oil Pricing Jumps Due to Continuing Middle East Conflict and Rising Uncertainty in Strait of Hormuz

Vivakor, Inc. (Nasdaq: VIVK) has reported increased activity in its Supply and Trading business, VST, driven by geopolitical instability in the Middle East and rising oil prices. The company attributes this growth to its strategic expansion, recurring contracted volumes, and expanding commercial relationships. Vivakor …

Vivakor (Nasdaq:VIVK) - Stock Analysis

This Simply Wall St stock analysis provides an overview of Vivakor (VIVK), a company involved in crude oil transportation, terminaling, and marketing. It highlights the company's low valuation, poor past performance, and high share price volatility, alongside a significant decline in earnings and shareholder …

How (INVA) Movements Inform Risk Allocation Models

This article analyzes Innoviva Inc. (NASDAQ: INVA) using AI models, identifying divergent sentiment across time horizons and suggesting choppy market conditions. It provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for support and resistance …

Viva Energy (ASX:VEA) Shares in Focus as Energy Sector Gains Investor Attention

Viva Leisure (ASX:VVA) — Is This ASX Fitness Stock Breaking Out?

Innoviva stock price target reiterated at $46 by H.C. Wainwright

H.C. Wainwright reiterated a Buy rating and a $46 price target for Innoviva (NASDAQ:INVA) after the company surpassed second-quarter revenue forecasts. Despite a reported net loss of $108 million due to investment value changes, the firm raised its full-year 2026 revenue forecast while maintaining …

Vivakor Targets $2 Billion in Annualized Crude Trading Through VST

Vivakor Supply & Trading (VST), a subsidiary of Vivakor, has signed new twelve-month WTI crude sales contracts aiming for a $2 billion annualized commercial activity target. These contracts run from September 1, 2026, to August 31, 2027, as part of Vivakor's expanding physical crude …

Innoviva, Inc. (INVA) Stock Forecasts

Argus has lowered its target price for Innoviva Inc. (INVA) to $23.00, according to a report published on August 5, 2026. Innoviva Inc. is described as a company holding a portfolio of royalties in healthcare assets, including a royalty portfolio, operating assets in critical …

Vivakor subsidiary signs crude oil trading contracts By Investing.com

Vivakor Inc.'s subsidiary, Vivakor Supply & Trading, has secured 12-month crude oil trading contracts for 2.4 million barrels annually, starting September 1, 2026. These agreements involve 200,000 barrels of West Texas Intermediate crude oil per month and are expected to contribute to nearly $2 …

VIVK Stock Surges As Crude Deals Lift Trading Platform To $1.5B

Vivakor Inc. (VIVK) stock surged 16.37% following news of new crude oil marketing contracts, which have elevated its annualized commercial platform to approximately $1.5 billion and 18.4 million barrels per year. Despite this operational momentum, the company's financials still show losses and negative cash …

VIVK Stock Rockets As Crude Trading Platform Tops $1.5B

Vivakor Inc. (VIVK) stock surged over 16% due to heightened optimism following its strategic expansion in crude trading. The company's supply and trading arm has expanded its annualized activity to roughly $1.5 billion and 18.4 million barrels per year for 2026/2027. Despite significant stock …

Vivakor's crude oil trading hits 2.4M barrels a...

Vivakor's subsidiary, Vivakor Supply & Trading, LLC, has secured new 12-month contracts to sell 200,000 barrels of West Texas Intermediate crude oil monthly, totaling 2.4 million barrels annually starting September 2026. This expansion brings Vivakor closer to $2 billion in annualized commercial activity, indicating …

Vivakor Accelerates Crude Oil Trading Portfolio toward $2 Billion in Annualized Commercial Activity

New 12-month transactions add 2.4 million barrels of annual sales volume Dallas, TX, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Vivakor, Inc. (Nasdaq: VIVK) ("Vivakor" or the "Company"), an integrated provider of energy transportation, storage, reuse and remediation services, today announced that its subsidiary, Vivakor …

200,000 barrels a month: Vivakor's new crude deals set to start Sept. 1

Vivakor (Nasdaq: VIVK) announced that its subsidiary, Vivakor Supply & Trading (VST), has secured new 12-month agreements to sell 200,000 barrels of WTI crude per month, totaling 2.4 million barrels annually. These transactions, starting September 1, 2026, and running through August 31, 2027, will …

Viva Goods Schedules Board Meeting to Approve Interim Results and Consider Dividend

Vivakor Inc (VIVK) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Vivakor Inc (VIVK), detailing its current stock price, market capitalization, and a list of peer companies for comparison. It highlights that the financial forecasting includes EPS, Revenue, Net Profit, and EBIT, with the data updated on August …

Viva Leisure Sets Date for FY2026 Results and Investor Webinar

AVIVA PLC (AV.L) Stock Analysis: Navigating the 37.10% Revenue Growth Amidst a 5.52% Dividend Yield

Does Innoviva’s Q2 Loss and Buyback-Fuled EPS Shift Change The Bull Case For INVA?

Innoviva, Inc. reported a Q2 2026 net loss of US$83.42 million despite increased revenue, leading to a loss per share of US$1.14 from continuing operations. This quarterly loss contrasts with strong first-half net income, creating a volatile earnings picture. The company's recent US$66.40 million …

Innoviva (INVA) Stock Can Revenue Growth Offset A Sharp Profit Reversal

Innoviva (INVA) stock saw a 2.9% increase despite a significant Q2 2026 profit reversal, swinging from a profit of US$63.7 million to a loss of US$83.4 million. The company's revenue, however, grew by 19% to US$119.6 million, driven by its Specialty Therapeutics portfolio and …

How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors

Innoviva, Inc. reported mixed Q2 2026 results with increased revenue but a swing from net income to a significant net loss, while also completing a substantial share repurchase. This financial performance and capital allocation strategy may prompt investors to re-evaluate the company's investment narrative, …

Innoviva Inc (INVA) Stock News Today

This article provides current stock information for Innoviva Inc (INVA), including its stock price, market cap, and P/E TTM. It indicates that further news, earnings reports, analyst ratings, and key developments are anticipated to be published soon on the platform. The page primarily serves …